Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended DECEMBER 31, 2019 Or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from TO Commission File Number: 001-36046 AXOGEN, INC. (Exact name of registrant as specified in its charter) MINNESOTA 41-1301878 (State or other jur ...

AxoGen, Inc. (NASDAQ:AXGN) Q3 2019 Earnings Conference Call November 6, 2019 4:30 PM ET Company Participants Pete Mariani - Chief Financial Officer Karen Zaderej - Chairman, Chief Executive Officer & President Conference Call Participants Jaime Lynn - SVB Leerink Raj Denhoy - Jefferies Operator Welcome to the AxoGen Inc. Third Quarter 2019 Fiscal Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Ins ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to______________ Commission file number: 001-36046 Axogen, Inc. (Exact Name of Registrant as Specified in Its Charter) | -- ...

AxoGen, Inc. (NASDAQ:AXGN) Q2 2019 Earnings Conference Call August 6, 2019 4:30 PM ET Company Participants Kaila Krum - Vice President of Investor Relations and Corporate Development Karen Zaderej - Chairman, Chief Executive Officer, and President Peter Mariani - Chief Financial Officer Conference Call Participants Richard Newitter - Leerink Partners Raj Denhoy - Jefferies Ryan Zimmerman - BTIG Craig Bijou - Cantor Fitzgerald Andrew Brackmann - William Blair Kyle Rose - Canaccord Operator Greetings. And wel ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ____________ to______________ Commission file number: 001-36046 Axogen, Inc. (Exact Name of Registrant as Specified in Its Charter) | --- | - ...

AxoGen, Inc. (NASDAQ:AXGN) Q1 2019 Earnings Conference Call May 8, 2019 4:30 PM ET Company Participants Kaila Krum – Vice President of Investor Relations and Corporate Development Karen Zaderej – Chairman, Chief Executive Officer and President Pete Mariani – Chief Financial Officer Conference Call Participants Raj Denhoy – Jefferies Jamie Aframe – Leerink Partners Andrew Brackmann – William Blair Sam Brodovsky – BTIG Craig Bijou – Cantor Fitzgerald Operator Greetings. Welcome to the AxoGen’s First Quarter 2 ...